The Latest “Buzz on the Street” Show: Featuring Cannabix Technologies (OTC: BLOZF) (CSE: BLO) News

Published on: 29 Jan, 2019


FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Cannabix Technologies Completes Breath Collection Unit and Provides Update”

Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO) Frankfurt (8CT: FRA) is a Vancouver, B.C. based technology company. Cannabix is developing tools for law enforcement and the workplace to detect THC in breath. Cannabix Technologies’ common shares are listed on the Canadian Securities Exchange, quoted on the US OTC Exchange and European Frankfurt Exchange.

Cannabix Technologies has reported that it has received an initial version of its portable handheld device that will provide for the easy collection of breath samples at the point of care. The BCU is a proprietary device that will make it easier to collect key physiologic breath sample data under different environmental conditions to determine the effects of such parameters on a ?9-tetrahydrocannabinol (“THC”) breath sample.

For more information, please visit: Cannabix Technologies Inc.

For more corporate news on WeedMD Inc., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Ratings

Ratings
  • 4605Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Carlos Braadt

Email: Carlos@financialinsiders.com

@Newsletter

Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

26 Jun, 2017 1310
03 Jul, 2017 1124
01 Aug, 2017 1569
30 Aug, 2017 11844

Comments

There is no comment on this article